-
公开(公告)号:US20050222236A1
公开(公告)日:2005-10-06
申请号:US11062305
申请日:2005-02-18
申请人: Youla Tsantrizos , Catherine Chabot , Pierre Beaulieu , Christian Brochu , Martin Poirier , Timothy Stammers , Bounkham Thavonekham , Jean Rancourt
发明人: Youla Tsantrizos , Catherine Chabot , Pierre Beaulieu , Christian Brochu , Martin Poirier , Timothy Stammers , Bounkham Thavonekham , Jean Rancourt
IPC分类号: A61K31/4184 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D487/04 , C07D43/02
CPC分类号: C07D487/04 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04
摘要: An enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein A, B, R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are as defined herein, or a salt or ester thereof, as an inhibitor of HCV NS5B polymerase.
摘要翻译: 由式I表示的化合物的对映体,非对映异构体或互变异构体:其中A,B,R 1,R 2,R 3, R 4,R 5,R 6,R 7,R 8, R 9和R 10如本文所定义,或其盐或酯作为HCV NS5B聚合酶的抑制剂。
-
公开(公告)号:US07879851B2
公开(公告)日:2011-02-01
申请号:US12372533
申请日:2009-02-17
申请人: Youla S. Tsantrizos , Catherine Chabot , Pierre Beaulieu , Christian Brochu , Martin Poirier , Timothy A. Stammers , Bounkham Thavonekham , Jean Rancourt
发明人: Youla S. Tsantrizos , Catherine Chabot , Pierre Beaulieu , Christian Brochu , Martin Poirier , Timothy A. Stammers , Bounkham Thavonekham , Jean Rancourt
IPC分类号: A61K31/5377 , A61K31/4439 , A61K31/4184 , C07D413/14 , C07D401/14 , C07D235/04
CPC分类号: C07D487/04 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04
摘要: An enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein A, B, R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are as defined herein, or a salt or ester thereof, as an inhibitor of HCV NS5B polymerase.
摘要翻译: 由式I表示的化合物的对映体,非对映异构体或互变异构体:其中A,B,R 1,R 2,R 3,R 4,R 5,R 6,R 7,R 8,R 9和R 10如本文所定义, 作为HCV NS5B聚合酶的抑制剂。
-
公开(公告)号:US08030309B2
公开(公告)日:2011-10-04
申请号:US12891112
申请日:2010-09-27
申请人: Youla S. Tsantrizos , Catherine Chabot , Pierre Beaulieu , Christian Brochu , Martin Poirier , Timothy A. Stammers , Bounkham Thavonekham , Jean Rancourt
发明人: Youla S. Tsantrizos , Catherine Chabot , Pierre Beaulieu , Christian Brochu , Martin Poirier , Timothy A. Stammers , Bounkham Thavonekham , Jean Rancourt
IPC分类号: A61K31/501 , A61K31/497 , A61K31/4427 , C07D401/14 , C07D413/14
CPC分类号: C07D487/04 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04
摘要: An enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein A, B, R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are as defined herein, or a salt or ester thereof, as an inhibitor of HCV NS5B polymerase.
-
公开(公告)号:US07582770B2
公开(公告)日:2009-09-01
申请号:US11062305
申请日:2005-02-18
申请人: Youla S. Tsantrizos , Catherine Chabot , Pierre Beaulieu , Christian Brochu , Timothy A. Stammers , Bounkham Thavonekham , Jean Rancourt
发明人: Youla S. Tsantrizos , Catherine Chabot , Pierre Beaulieu , Christian Brochu , Timothy A. Stammers , Bounkham Thavonekham , Jean Rancourt
IPC分类号: C07D235/04 , C07D487/00 , C07D233/02 , C07D207/00 , C07D209/04 , A61K31/415 , A61K31/40 , A61K31/405
CPC分类号: C07D487/04 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04
摘要: An enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein A, B, R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are as defined herein, or a salt or ester thereof, as an inhibitor of HCV NS5B polymerase.
摘要翻译: 由式I表示的化合物的对映异构体,非对映异构体或互变异构体:其中A,B,R1,R2,R3,R4,R5,R6,R7,R8,R9和R10如本文所定义,或盐或酯 作为HCV NS5B聚合酶的抑制剂。
-
公开(公告)号:US20070142380A1
公开(公告)日:2007-06-21
申请号:US11672293
申请日:2007-02-07
申请人: Pierre Beaulieu , Christian Brochu , Catherine Chabot , Eric Jolicoeur , Stephen Kawai , Marc-Andre Poupart , Youla Tsantrizos
发明人: Pierre Beaulieu , Christian Brochu , Catherine Chabot , Eric Jolicoeur , Stephen Kawai , Marc-Andre Poupart , Youla Tsantrizos
IPC分类号: A61K31/53 , A61K31/519 , A61K31/503 , A61K31/498 , C07D487/04
CPC分类号: C07D401/04 , C07D209/08 , C07D209/30 , C07D401/06 , C07D401/14 , C07D405/04 , C07D405/14 , C07D409/04 , C07D409/14 , C07D413/14 , C07D417/14 , C07D513/04
摘要: An isomer, enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein A, B, R2, R3, L, M1, M2, M3, M4, Y1, Y0, Z and Sp are as defined in claim 1, or a salt thereof, as an inhibitor of HCV NS5B polymerase.
摘要翻译: 由式I表示的化合物的异构体,对映体,非对映异构体或互变异构体:其中A,B,R 2,R 3,L,M 1, M 2,M 3,M 4,Y 1,Y 0, / SUP>,Z和Sp如权利要求1中所定义,或其盐作为HCV NS5B聚合酶的抑制剂。
-
公开(公告)号:US07888363B2
公开(公告)日:2011-02-15
申请号:US11672293
申请日:2007-02-07
申请人: Pierre Louis Beaulieu , Christian Brochu , Catherine Chabot , Eric Jolicoeur , Stephen Kawai , Marc-André Poupart , Youla S. Tsantrizos
发明人: Pierre Louis Beaulieu , Christian Brochu , Catherine Chabot , Eric Jolicoeur , Stephen Kawai , Marc-André Poupart , Youla S. Tsantrizos
IPC分类号: A61K31/497 , C07D403/00
CPC分类号: C07D401/04 , C07D209/08 , C07D209/30 , C07D401/06 , C07D401/14 , C07D405/04 , C07D405/14 , C07D409/04 , C07D409/14 , C07D413/14 , C07D417/14 , C07D513/04
摘要: An isomer, enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein A, B, R2, R3, L, M1, M2, M3, M4, Y1, Y0, Z and Sp are as defined in claim 1, or a salt thereof, as an inhibitor of HCV NS5B polymerase.
摘要翻译: 由式I表示的化合物的异构体,对映体,非对映异构体或互变异构体:其中A,B,R2,R3,L,M1,M2,M3,M4,Y1,Y0,Z和Sp如权利要求1所定义, 或其盐作为HCV NS5B聚合酶的抑制剂。
-
公开(公告)号:US07223785B2
公开(公告)日:2007-05-29
申请号:US10755256
申请日:2004-01-12
IPC分类号: A61K31/40 , C07D209/42
CPC分类号: C07D401/04 , C07D209/08 , C07D209/30 , C07D401/06 , C07D401/14 , C07D405/04 , C07D405/14 , C07D409/04 , C07D409/14 , C07D413/14 , C07D417/14 , C07D513/04
摘要: An isomer, enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein wherein A, B, R2, R3, L, M1, M2, M3, M4, Y1, Y0, Z and Sp are as defined in claim 1, or a salt thereof, as an inhibitor of HCV NS5B polymerase.
摘要翻译: 由式I表示的化合物的异构体,对映体,非对映异构体或互变异构体:其中A,B,R 2,R 3,L,M 1 M 2,M 3,M 3,S 4,Y 1,Y 0, Z和Sp如权利要求1中所定义,或其盐作为HCV NS5B聚合酶的抑制剂。
-
公开(公告)号:US06211170B1
公开(公告)日:2001-04-03
申请号:US09167141
申请日:1998-10-06
申请人: Christiane Yoakim , Robert Déziel , Stephen Kawai , William W. Ogilvie , Jeffrey O'Meara , Catherine Chabot
发明人: Christiane Yoakim , Robert Déziel , Stephen Kawai , William W. Ogilvie , Jeffrey O'Meara , Catherine Chabot
IPC分类号: C07D20508
CPC分类号: C07D205/08 , C07D403/12
摘要: A compound of formula I: wherein R1 is hydrogen, methyl, ethyl, methoxy or methylthio; R2 and R3 each independently is hydrogen or C1-3 alkyl; R4 is hydrogen, lower alkyl, methoxy, ethoxy, or benzyloxy; R5 is lower alkyl, lower cycloalkyl, (CH2)mC(O)OR6 wherein m is the integer 1 or 2 and R6 is lower alkyl, phenyl optionally substituted with C(O)OR7 wherein R7 is lower alkyl or phenyl (lower alkyl); or R6 is Het or Het(lower alkyl; or R4 and R5 together with the nitrogen atom to which they are attached form a nitrogen containing ring optionally substituted with benzyloxycarbonyl or with phenyl optionally substituted among other group with C(O)OR7 wherein R7 is lower alkyl or (lower alkyl)phenyl; X is selected from the group consisting of O, S, SO, SO2, NR8, wherein R8 is H or lower alkyl; and Y is C1-10 non-cyclic or cyclic alkyl; [(CH2)0-1]-phenyl, said phenyl ring optionally substituted; Het or Het(lower alkyl); or when X is NR8, wherein R8 is lower alkyl and Y is lower alkyl or lower alkoxy, X and Y are joined together to form a morpholino or piperidino ring; or a therapeutically acceptable acid addition salt thereof, which compound is useful in the treatment of HCMV infection.
摘要翻译: 式I的化合物:其中R 1是氢,甲基,乙基,甲氧基或甲硫基; R2和R3各自独立地为氢或C1-3烷基; R4是氢,低级烷基,甲氧基,乙氧基或苄氧基; R5是低级烷基,低级环烷基,(CH2)mC(O)OR6,其中m是整数1或2,R6是低级烷基,任选被C(O)OR 7取代的苯基,其中R 7是低级烷基或苯基(低级烷基) ; 或R6是Het或Het(低级烷基;或R4和R5与它们所连接的氮原子一起形成任选被苄氧基羰基取代的含氮环或与C(O)OR 7任选取代的苯基,其中R 7是 低级烷基或(低级烷基)苯基; X选自O,S,SO,SO 2,NR 8,其中R 8为H或低级烷基; Y为C 1-10非环状或环状烷基; [(CH 2 )0-1] - 苯基,所述苯环任选被取代; Het或Het(低级烷基);或当X是NR8时,其中R8是低级烷基,Y是低级烷基或低级烷氧基,X和Y连接在一起形成 吗啉或哌啶子基环;或其治疗上可接受的酸加成盐,该化合物可用于治疗HCMV感染。
-
-
-
-
-
-
-